| 12281153 |
Combination therapy with targeted 4-1BB (CD137) agonists |
Christina Claus, Claudia Ferrara Koller, Christian Klein, Pablo Umana |
2025-04-22 |
| 12098213 |
Antibodies binding to HLA-A2/WT1 |
Joerg Benz, Christian Klein, Stefan Klostermann, Ekkehard Moessner, Pablo Umana +3 more |
2024-09-24 |
| 11780919 |
Bispecific antigen binding molecules targeting OX40 and FAP |
Maria Amann, Juergen Peter BACHL, Alexander BUJOTZEK, Carina CANTRILL, Harald Duerr +12 more |
2023-10-10 |
| 11718680 |
Combination therapy of anti-CD20/anti-CD3 bispecific antibodies and 4-1BB (CD137) agonists |
Marina BACAC, Claudia Ferrara Koller, Christian Klein, Mario Perro, Pablo Umana +1 more |
2023-08-08 |
| 11608376 |
Tumor-targeted agonistic CD28 antigen binding molecules |
Guy Georges, Thomas Hofer, Ralf Hosse, Christian Klein, Ekkehard Moessner +5 more |
2023-03-21 |
| 11192957 |
Antibodies binding to HLA-A2/WT1 |
Joerg Benz, Christian Klein, Stefan Klostermann, Ekkehard Moessner, Pablo Umana +3 more |
2021-12-07 |
| 10596257 |
Methods of treating CEA-positive cancers using PD-1 axis binding antagonists and anti-CEA/anti-CD3 bispecific antibodies |
Marina BACAC, Sara COLOMBETTI, Christian Klein, Jose SARO, Pablo Umana |
2020-03-24 |
